If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Business Update

10 May 2012 07:00

RNS Number : 0316D
ViaLogy PLC
10 May 2012
 



VIALOGY ACHIEVES MAJOR COMMERCIAL MILESTONES

 

Pasadena, CA, May 10, 2012. ViaLogy PLC (LSE/AIM: VIY). In a business update issued today ViaLogy said the last two months marked a major progress milestone in the company's development. New commercial contracts have been signed with three of the largest global Exploration and Production (E&P) firms, including two supermajors. All are focused on putting the company's technology, QuantumRD, to operational use in some of the world's most important development fields, and aiming to improve significantly on industry-standard techniques now in use. The named contracts include the Oil and Natural Gas Corporation of India (ONGC), and Chevron.

The three areas covered by the contracts vary widely in their features; they are geographically distant from one another, and of distinct formation types - sandstones, carbonates, and non-conventional shale. Each has challenged best-of-practice conventional seismic analysis techniques. One is offshore in deepwater, one in an already heavily exploited onshore carbonate formation where secondary development and horizontal drilling are key factors, and one is a new development section of one of the world's largest and, until now, most productive fields. This variety of QuantumRD's applications emphasizes the broad utility of the signal processing technology in addressing E&P challenges worldwide.

The contracts also mark the company's move into the global geophysical services marketplace, with the objective that success in work underway will lead to widespread use of QuantumRD. The company is at work on winning other large operators and supermajors as clients, for some of whom difficult pilot projects have been completed. ViaLogy also continues to work with some of its smaller clients.

QuantumRD brings quantum physics and quantum mathematics to the challenge of processing seismic data to more effectively locate oil and gas, and to characterize reservoirs. More importantly, QuantumRD brings an important value proposition to the upstream E&P sector - simply put, to achieve cost savings associated with fewer or more efficient wells drilled per barrel of oil extracted.

CEO Robert Dean said, "Over the last few years, we've devoted every resource to breaking into the supermajor market. We adopted a strategy and are achieving our goals in deliberate fashion -identifying and developing the right clients, winning projects that subject the technology to rigorous technical scrutiny, and demonstrating its global reach. This is not an event; it's a process. We believe we are well on our way. From an initial successful project in south central Texas, and also counting some disappointments, we're now working in the world's most challenging fields - such as offshore India -- and with the world's most important companies. Our current contracts are sizable; larger ones should follow. The technology is under sustained technical scrutiny by the finest in the industry; we ourselves have more development work to do. But we believe ViaLogy has passed the tipping point."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDGGDUGUGBGDC
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.